Cargando…
Exists a role for serum irisin in Egyptian Behcet’s patients with subclinical atherosclerosis?
OBJECTIVES: To examine the serum irisin level in a group of Behcet’s disease patients, its association with illness parameters, and its utility in diagnosing subclinical atherosclerosis. METHODS: This randomized case–control study included 50 patients and 50 age- and sex-matched controls. Carotid Do...
Autores principales: | Ismail, Mohamed A., Mounir, Ola, Sedky, Ahmed, Algahlan, Hisham A., Abda, Esam A., Radwan, Ahmed R., Abozaid, Hanan Sayed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9823020/ https://www.ncbi.nlm.nih.gov/pubmed/36112245 http://dx.doi.org/10.1007/s10067-022-06368-9 |
Ejemplares similares
-
Novel myokine: irisin may be an independent predictor for subclinic atherosclerosis in Behçet's disease
por: Icli, Abdullah, et al.
Publicado: (2016) -
Serum Endocan Levels and Subclinical Atherosclerosis in Behçet’s Syndrome
por: Nassef, Eman Mostafa, et al.
Publicado: (2022) -
Irisin as a Novel Biomarker of Subclinical Atherosclerosis in Severe Obesity
por: Carmona-Maurici, Júlia, et al.
Publicado: (2023) -
Serum irisin and apelin levels and markers of atherosclerosis in patients with subclinical hypothyroidism
por: Yasar, Hamiyet Yilmaz, et al.
Publicado: (2019) -
Prevalence of Subclinical Peripheral Vascular Disease in Obese Egyptian Patients
por: Younes, Jehan Ahmed, et al.
Publicado: (2017)